Based on the measurements of operating efficiency obtained from MEDIFAST INC's historical financial statements, MEDIFAST INC is performing exceptionally good at this time. It has a great probability to report excellent financial results in December. At present, MEDIFAST INC's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 50.9 M, whereas Common Stock Total Equity is forecasted to decline to about 12.3 K. Key indicators impacting MEDIFAST INC's financial strength include:
The financial analysis of MEDIFAST INC is a critical element in measuring its lifeblood. Investors should not minimize MEDIFAST INC's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Cash And Equivalents
100.8 Million
MEDIFAST
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Dividends Paid
Change To Account Receivables
Sale Purchase Of Stock
Change To Liabilities
Change To Netincome
Stock Based Compensation
Investments
Change Receivables
Net Borrowings
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Other Cashflows From Investing Activities
Change To Operating Activities
Exchange Rate Changes
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Good Will
Common Stock Total Equity
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Short Term Debt
Intangible Assets
Common Stock
Accounts Payable
Accumulated Other Comprehensive Income
Other Assets
Long Term Debt
Short Term Investments
Property Plant Equipment
Treasury Stock
Current Deferred Revenue
Net Tangible Assets
Retained Earnings Total Equity
Capital Surpluse
Capital Lease Obligations
Other Liab
Cash And Equivalents
Net Invested Capital
Net Working Capital
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Extraordinary Items
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Research Development
Non Operating Income Net Other
Selling And Marketing Expenses
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past MEDIFAST INC Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of MEDIFAST INC's financial statements are interrelated, with each one affecting the others. For example, an increase in MEDIFAST INC's assets may result in an increase in income on the income statement.
Please note, the presentation of MEDIFAST INC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MEDIFAST INC's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MEDIFAST INC's management manipulating its earnings.
MEDIFAST INC Stock Summary
MEDIFAST INC competes with Rollins, Carriage Services, Service International, Bright Horizons, and HR Block. Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Medifast operates under Personal Services classification in the United States and is traded on New York Stock Exchange. It employs 984 people.
Comparative valuation techniques use various fundamental indicators to help in determining MEDIFAST INC's current stock value. Our valuation model uses many indicators to compare MEDIFAST INC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MEDIFAST INC competition to find correlations between indicators driving MEDIFAST INC's intrinsic value. More Info.
MEDIFAST INC is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 1.30 of Return On Asset per Return On Equity. At present, MEDIFAST INC's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value MEDIFAST INC by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
MEDIFAST INC Systematic Risk
MEDIFAST INC's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MEDIFAST INC volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on MEDIFAST INC correlated with the market. If Beta is less than 0 MEDIFAST INC generally moves in the opposite direction as compared to the market. If MEDIFAST INC Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MEDIFAST INC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MEDIFAST INC is generally in the same direction as the market. If Beta > 1 MEDIFAST INC moves generally in the same direction as, but more than the movement of the benchmark.
MEDIFAST INC Thematic Clasifications
MEDIFAST INC is part of Food Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Food Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Food Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in MEDIFAST INC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MEDIFAST INC's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of MEDIFAST INC growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.24)
At present, MEDIFAST INC's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
MEDIFAST INC November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MEDIFAST INC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MEDIFAST INC. We use our internally-developed statistical techniques to arrive at the intrinsic value of MEDIFAST INC based on widely used predictive technical indicators. In general, we focus on analyzing MEDIFAST Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MEDIFAST INC's daily price indicators and compare them against related drivers.
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance